Aristotle University Of Thessaloniki (AUTH)
Φλεγμονώδη νοσήματα του εντέρου και δείκτες πρώιμης αθηροσκλήρωσης
Abstract
dc:descriptionAtherosclerosis is an inflammatory process of the arterial wall, and inflammation is an independent risk factor for cardiovascular disease (CVD). The association between inflammatory bowel diseases (IBD) and CVD remains equivocal. The aim of this study was to assess non-invasive markers of CV risk, carotid intima-media thickness (cIMT), arterial stiffness as assessed by pulse wave velocity (cfPWV), and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, as well as the levels of the adipokines resistin and adiponectin that play a role in both inflammation and likely atherosclerosis, in patients with IBD without history of CVD compared to a group of matched controls for traditional CVD risk factors. We included 44 patients with IBD, 29 with Crohn’s disease (CD) and 15 with ulcerative colitis (UC), and 44 controls matched for age, gender, body mass index (BMI) and smoking habits. Established CVD risk factors and IBD characteristics (disease duration, extent of bowel involvement, disease activity and treatment) were recorded. IBD patients had lower haemoglobin, total cholesterol, low-density lipoprotein cholesterol (LDL-C) and folic acid levels, and higher platelet count. cIMT was significantly higher in IBD patients compared to controls (0.62 vs. 0.52 mm; p<0.0005). There was no difference in cIMT between patients with CD and UC. Factors associated with cIMT were age, BMI and presence of IBD, with the latter making the greater unique contribution. There was no difference in cfPWV between patients and controls (6.8 vs. 6.4 m/s), but patients with CD had higher cfPWV compared to those with UC (7 vs. 6.3 m/s; p=0.044), and to controls. Smoking rates were significantly higher among CD patients. Factors associated with cfPWV were age, mean arterial pressure and smoking. Lp-PLA2 activity was significantly lower in patients with IBD (46.8 vs. 53.9 nmol/ml/min; p=0.011), but there was no difference in Lp-PLA2 to LDL-C ratio between the two groups. There was no difference in Lp-PLA2 between CD and UC patient. LDL-C was the only significant predictor of Lp-PLA2 activity. Resistin levels were significantly higher in IBD patients (13.7 vs. 10 ng/mL; p=0.022), but there was no difference in adiponectin levels. Resistin levels were significantly higher in patients with active disease (18.9 vs. 11.3 ng/mL; p=0.014). Adiponectin levels correlated inversely with both cIMT (rho=-0.255; p=0.021) and cfPWV (rho=-0.434; p<0.0005). This study showed increased cIMT in patients with IBD, and that IBD is a significant predictor of increased cIMT even when other CVD risk factors are taken into consideration. These findings are highly suggestive of an association between early arterial wall alterations and inflammation in IBD. Arterial stiffness and Lp-PLA2/LDL-C ratio are likely less sensitive markers. Adiponectin is inversely associated with arterial changes and might play a protective role.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Theocharidou, Eleni
- Θεοχαρίδου, Ελένη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38190